BioInterface 2020 – Workshop & Symposium
Wednesday, October 28, 2020 11:05 a.m. PT Joshua Schmidt, SenzaGen, Inc. "Leveraging in vitro to forecast in vivo success"
Wednesday, October 28, 2020 11:05 a.m. PT Joshua Schmidt, SenzaGen, Inc. "Leveraging in vitro to forecast in vivo success"
New Approach Methodology Use for Regulatory Application (NURA) in collaboration with the Association for the Advancement of Alternatives Assessment (A4) is hosting two half day trainings to explore practical solutions for the […]
Monday November 16, 2020 5:00 PM–6:30 PM EST Virtual Poster Session: Dose-Response Analysis in GARD for Assessment of Skin Sensitizer Potency Applicability of GARDskin for Accurate Assessment of Challenging Substances […]
This day is offering a theoretical base with different lectures on research forefront and financing opportunities. The workshop originally included a practical session on site, but due to the covid-19 […]
Dec. 1st at 1:10pm EDT As part of the "Sensitization: Skin & Beyond" science panel, Dr. Andy Forreryd at SenzaGen will be presenting a talk titled: "The GARD Platform for […]
In vitro, high accuracy, broad applicability Join this free webinar to learn how the GARD™ assays, based on genomics and machine learning, provide a highly accurate method for skin sensitization […]
User cases on hazard and potency assessment Join us for this free webinar to get the latest news about the in vitro GARD™ assays and how they are used across […]
Webinaire en français (in French) Participez à ce webinaire sur les nouvelles technologies in vitro utilisées pour l’évaluation des produits cosmétiques organisé par PKDerm, GenEvolutioN et SenzaGen avec la participation de CEHTRA […]
Booth #2062 Program The official meeting time zone is US Eastern Daylight Time, UTC -4. Please consult the World Time Zone Map for further guidance regarding the time conversions. March 16 […]
In case you missed our poster presentations at this year's Society of Toxicology Annual Meeting, here is a new opportunity. Register to get the latest updates on the GARD™ assays and […]